In the News
What’s new in the world of Allen Carr’s Easyway and vaping
Show category filters
For over 20 years we have been helping people overcome their addiction to vaping and enjoy freedom from vaping. Explore our advice on multiple topics here
Discover the latest facts and information about Vaping
Learn how different aspects of your physical and mental health can be affected by vaping and improved by quitting
What’s new in the world of Allen Carr’s Easyway and vaping
Life as a happy non-smoker is full of freedom and joy. Here are our tips and advice for the future.
Testimonials both written and video from some well known faces all given freely to inspire others to freedom.
Hosted by Allen Carr’s Easyway CEO and Senior Therapist John Dicey & Colleen Dwyer, this podcast addresses all aspects of addiction and getting free.
Featured articles
January 2024
Allen Carr’s Easyway have been highlighting the risk to young people for many years.
January 2024
TalkTV live interview with Paul Baker CFO & NHS Liaison Allen Carr's Easyway discussing the UK disposable vape ban
January 2024
Written warning sent by Met Police about the risks of vaping after children hospitalized.
All Articles
230
items
June 2016
An extraordinary announcement by Action on Smoking and Health saying "Quitting smoking could be responsible for increased incidence of Parkinson’s disease" but not true.
May 2016
The results of the Irish RCT on Allen Carr's Easyway was presented to 7th European conference Tobacco or Health (ECTOH)
March 2016
The presentation that BIG TOBACCO, BIG PHARMA, the anti-tobacco & tobacco control establishment DON'T WANT YOU TO SEE!!
December 2015
Allen Carr’s Easyway, the world-leading smoking-cessation method for the past 30 years, has polled 1,000 non-smokers throughout the UK, to gauge their opinions on the new policy.
November 2015
Allen Carr’s Easyway is delighted to announce the launch of stop smoking clinics as a franchise offering in the USA for the first time.
July 2015
Allen Carr’s Easyway is taking part in a clinical trial in Dublin, Ireland to asses our overall success rate in comparison to Irish Health authorities.
